Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 659754Generated: October 23, 2026

Piperazine Dihydrochloride → Irbesartan

https://huagongshe.com/en/reaction/659754

Reaction equation

Participants

RoleNameHCIDCharge
ReactantPiperazine DihydrochlorideHCID 8893—
ReactantSodium AzideHCID 33557—
Reactant4'-((2-Butyl-4-oxo-1,3-diazaspiro(4.4)non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrileHCID 9843116—
SolventO-XyleneHCID 7237—
ProductIrbesartanHCID 374996%

Reaction Steps

A mixture of 2-n-butyl-3-[(2′-cyanobiphenyl-4-yl)methyl]-1,3-diazaspiro-[4,4]-non-1-en-4-one (10 g), sodium azide (7.7 g) and piperazine dihydrochloride (7.5 g) in xylene (30 ml) was refluxed for 7 hours under stirring. The reaction was cooled to room temperature and extracted with 5% NaOH solution. The pooled alkaline solution was washed with toluene or xylene (15 ml) and the aqueous phase neutralized to pH 6.5 using concentrated HCL. The resulting suspension was stirred for 3 hours at room temperature and filtered obtain irbesartan (3.6 g, 96% purity by HPLC).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08080670B2
Source datasetuspto-grants-2011_12
ORD IDord-a67296b3abe540c4a17ddd7e7fd19fb6
Source noteuspto-grants-2011_12